Common Variation in Genes Involved in HDL Metabolism Influences Coronary Heart Disease Risk at the Population Level

ISSN： 1389-9155

Source： Reviews in Endocrine and Metabolic Disorders, Vol.5, Iss.4, 2004-12, pp. : 343-349

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic Targets to Raise HDL in Patients at Risk or with Coronary Artery Disease

Current Vascular Pharmacology, Vol. 10, Iss. 6, 2012-11 ,pp. : 720-724

Bentham Science Publishers

Access to resources Recommend Favorite

The Potential of SERMs for Reducing the Risk of Coronary Heart Disease

By Barrett-Connor E. Cox D.A. Anderson P.W.

Trends in Endocrinology and Metabolism, Vol. 10, Iss. 8, 1999-10 ,pp. : 320-325

Elsevier

Access to resources Recommend Favorite

Urinary isoflavonoids and risk of coronary heart disease

By Zhang Xianglan

International Journal of Epidemiology, Vol. 41, Iss. 5, 2012-10 ,pp. : 1367-1375

Oxford University Press

Access to resources Recommend Favorite

Estrogen plus progestin and the risk of coronary heart disease

By Manson J.E. Hsia J. Johnson K.C. for the Women's Health Initiative Investigators

ACC Current Journal Review, Vol. 12, Iss. 6, 2003-11 ,pp. : 24-24

Elsevier

Access to resources Recommend Favorite

Hematological Risk Factors for Coronary Heart Disease

Medical Principles and Practice, Vol. 11, Iss. 2, 2002-11 ,pp. : 56-62

Karger

Access to resources Recommend Favorite